technetium tc-99m pentetate kit (renotec) Report issue

Small molecule Imaging Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA MeSH PubChem

Active Ingredient History

NOW
  • Now
8-Hydroxyquinoline is an organic compound derived from the heterocycle quinoline. A colorless solid, its conjugate base is a chelating agent, which is used for the quantitative determination of metal ions.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Imaging: 99-technetium
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$1227.3000 - $1764.8200
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

(111in)oxinate(3) | 111in-oxine | dtpa | human serum albumin diethylenetriaminepentaacetic acid technetium (99mtc) injection | in-111 oxyquinoline | indium (111 in) oxyquinoline | indium 111in oxyquinoline | indium-111in, tris(8-quinolinolato-n1,o8)- | indium-111 oxine | indium-111-oxine | indium-111-oxine sulfate | indium-111 oxyquinoline | indium (in111) oxine | indium in-111 oxine | indium in111 oxine | indium (in111) oxyquinoline | indium in 111 oxyquinoline | indium in-111 oxyquinoline | indium oxinate | indium oxine | indium oxine, 111in-labeled cpd | indium oxine, 113in-labeled cpd | indium oxine, 133in-labeled cpd | indium oxine in 111 | indium oxine sulfate, 111in-labeled cpd | indium oxyquinoline | mpi dtpa kit - chelate | oxine | tc 99m dtpa kit (chelate) | techneplex | technetium (99mtc) pentetic acid | technetium pentetate | technetium tc 99m pentetate | technetium tc-99m pentetate | technetium tc-99m pentetate kit | technetium tc 99m pentetate sodium

Organizations (10)

Research & Development (6)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (4)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (10)

Approved Indications (1)


 

Diagnostic Imaging (approved 1974)

Experimental Indications - Clinical Trial Phases 1-4 (9)


 

Diphtheria (Phase 4)

Immunization (Phase 4)

Lung Neoplasms (Early Phase 1)

Papillomavirus Infections (Phase 3)

Pertussis Vaccine (Phase 4)

Poliomyelitis (Phase 4)

Streptococcal Infections (Phase 3)

Tetanus (Phase 4)

Whooping Cough (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial Organizations: 6

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue